Mather Group LLC. Buys 247 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Mather Group LLC. increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 14.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,977 shares of the company’s stock after purchasing an additional 247 shares during the quarter. Mather Group LLC.’s holdings in GE HealthCare Technologies were worth $155,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Mesirow Financial Investment Management Inc. raised its holdings in GE HealthCare Technologies by 39.6% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company’s stock worth $383,000 after purchasing an additional 1,159 shares during the period. Cathy Pareto & Associates Inc. bought a new stake in GE HealthCare Technologies during the fourth quarter valued at about $670,000. LMR Partners LLP bought a new stake in GE HealthCare Technologies during the third quarter valued at about $7,387,000. Principal Financial Group Inc. raised its holdings in GE HealthCare Technologies by 1.9% during the third quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock valued at $94,780,000 after acquiring an additional 19,010 shares during the period. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new stake in GE HealthCare Technologies during the third quarter valued at about $1,396,000. 82.06% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have commented on GEHC. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company raised their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $96.00.

GE HealthCare Technologies Trading Down 1.0 %

GEHC opened at $87.64 on Friday. The firm has a market cap of $40.04 billion, a P/E ratio of 24.08, a P/E/G ratio of 2.92 and a beta of 1.14. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.55. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The stock has a 50-day moving average of $83.34 and a 200 day moving average of $85.21.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a $0.035 dividend. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 annualized dividend and a yield of 0.16%. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.85%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.